" Biotech stocks spiked higher on Wednesday after the U.S. government said that Medicare will be exhausted in 2028, two years sooner than projected last year.
In addition, the U.S. government said that a cost-cutting mechanism known as the Independent Payment Advisory Board (IPAB) is projected to be triggered in 2017.
According to Bloomberg, investors have been "nervously" awaiting on news for the IPAB determination on fears it could have been triggered in 2016 and set in motion reductions in Medicare payments to biotech and pharmaceutical companies."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.